The policy went into effect in September, and it expands access for the procedure to more than 36 million patients, according to a news release. Earlier this year, Intracept earned coverage from Cigna.
Intracept is a minimally invasive procedure for chronic vertebrogenic low back pain. More than 15,000 patients have been treated with Intracept.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
